IP Verse

Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders - EP3716992

PATENT ANALYSIS

Patent Details

Grant Date
Aug 10, 2022
Company
REGENERON PHARMACEUTICALS, INC.
Oppositions

AMGEN INC.

BOULT WADE TENNANT LLP

MAIWALD GMBH

WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB

More patents of Regeneron Pharmaceuticals, Inc.

EP4011915

EP2967015

EP3384049

Want to monitor this patent?

Feel free to send us a message here and we will get back to you